Top Markets
Coin of the day
BGI Genomics Co., Ltd. BGI Genomics Co., Ltd.

BGI Genomics Co., Ltd.

300676
株式のランク #5740
BGI Genomics Co., Ltd. operates as an international supplier of genetic testing... BGI Genomics Co., Ltd. operates as an international supplier of genetic testing solutions and sequencing services. The company caters to a broad clientele, encompassing medical and research facilities, as well as other public and private organizations, both within China and across the globe. Its comprehensive service portfolio includes DNA, RNA, and tailored sequencing options. Additionally, it offers a suite of specialized genetic tests such as non-invasive prenatal testing (NIPT), reproductive health screening, and newborn genetic screening, alongside clinical exome sequencing. BGI Genomics also develops clinical and research-focused solutions for the field of oncology. During the COVID-19 pandemic, the firm provided crucial laboratory solutions for the detection and diagnosis of suspected cases, including SARS-CoV-2 IgM and IgG antibody detection kits, and real-time fluorescent RT-PCR kits. Their expertise spans numerous research domains, including but not limited to agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug development. Established in 1999, the company initially operated under the name Shenzhen BGI Medicine Co., Ltd. before officially changing to BGI Genomics Co., Ltd. in 2015. Its corporate headquarters are located in Shenzhen, China.
株価
$5.91
時価総額
$2.47B
変化(1日)
0.10%
変化(1年)
-22.57%
CN
取引 BGI Genomics Co., Ltd. (300676)

カテゴリー

BGI Genomics Co., Ltd.(300676)の配当利回りの履歴
BGI Genomics Co., Ltd.(銘柄コード: 300676)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
BGI Genomics Co., Ltd.(300676)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)